‘Global warming’ to Mycobacterium avium subspecies paratuberculosis

September 6, 2014 Papers, Uncategorized 0

For over 30 years, Prof Hermon Taylor has been researching the role of MAP in the causation of Crohn’s disease and has been at the forefront of the science to develop a cure. In the latest paper ‘Global warming’ to Mycobacterium avium subspecies paratuberculosis from the Centre for Digestive Diseases in Australia, researchers highlight that theories once considered controversial can become accepted by the mainstream as scientific techniques improve. We are now reaching that point where the body of evidence linking MAP to Crohn’s is becoming so great, even the most ardent sceptic will find it difficult to dispute.

“The concept of CD being triggered by a Mycobacterium is gaining momentum with the advent of new molecular techniques and cytogenetics.
Mycobacterium avium subspecies paratuberculosis (MAP) is once again coming under the microscope due to the increased ability to detect its genetic signature. This is the best contender for a causative microorganism of CD which infects macrophages and disrupts the microbicidal and immune signaling function of these immune cells.”


The Crohn’s MAP Vaccine represents probably the most exciting treatment breakthrough in Crohn’s disease since Dr Burrill Crohn classified the disease in 1932, but don’t take our word for it; look at what the world-renowned team in Australia had to say in their paper published in July:

Developing therapeutic vaccination
One of the most exciting developments from John Hermon-Taylor’s laboratory is the anti-MAP vaccine capable of driving MAP from infected tissues [20]. It is envisaged that the stimulation of immune responses in the CD host, contrary to current immune-suppression, will be another co-therapy in the eradication of the intracellular pathogen/s driving the chronic inflammation in CD.